Schwartz T L, Nihalani N, Jindal S, Virk S, Jones N
SUNY Upstate Medical University, Department of Psychiatry, Syracuse, NY 13210, USA.
Obes Rev. 2004 May;5(2):115-21. doi: 10.1111/j.1467-789X.2004.00139.x.
A majority of psychiatric medications are known to generate weight gain and ultimately obesity in some patients. There is much speculation about the prevalence of weight gain and the degree of weight gain during acute and longitudinal treatment with these agents. There is newer literature looking at the aetiology of this weight gain and the potential treatments being used to alleviate this side-effect. We found solid evidence that weight gain is often associated with the mood stabilizers, and antipsychotics and antidepressants. Only few weight neutral or weight loss producing psychotropics are available, and weight gain, outside of an immediate side-effect, may generate secondary side-effects and medical comorbidity. Weight gain may cause hypertension, diabetes, osteoarthritis, sedentary lifestyle, coronary artery disease, etc. Given the likelihood of inducing weight gain with psychotropic medications and the longitudinal impact on physical health, a thorough literature review is warranted to determine the epidemiology, aetiology and treatment options of psychotropic-induced weight gain.
已知大多数精神科药物会导致一些患者体重增加并最终肥胖。关于这些药物在急性治疗和长期治疗期间体重增加的发生率以及体重增加的程度,有很多推测。有新的文献探讨了这种体重增加的病因以及用于减轻这种副作用的潜在治疗方法。我们发现确凿的证据表明,体重增加通常与心境稳定剂、抗精神病药物和抗抑郁药物有关。只有少数对体重无影响或能减轻体重的精神药物,而且体重增加除了是直接副作用外,还可能产生继发性副作用和合并症。体重增加可能导致高血压、糖尿病、骨关节炎、久坐不动的生活方式、冠状动脉疾病等。鉴于精神药物导致体重增加的可能性以及对身体健康的长期影响,有必要进行全面的文献综述,以确定精神药物所致体重增加的流行病学、病因和治疗选择。